Denosumab
Brand name: Prolia
Rank #92 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$199.4M
Total Cost
114,710
Total Claims
$199.4M
Total Cost
3,732
Prescribers
$1,738
Cost per Claim
60,667
Beneficiaries
652,357
30-Day Fills
$53K
Avg Cost/Provider
31
Avg Claims/Provider
Share of Medicare Part D Spending
0.07%
of total Medicare Part D spending
$199.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $199.4M total
🔎 Data Overview
At $1,738 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Denosumab
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Afshine Emrani | Cardiology | Tarzana, CA | 575 | $991K |
| 2 | Ericsson Trieu | Physician Assistant | Whittier, CA | 603 | $983K |
| 3 | Jaesoo Pak | Internal Medicine | Cerritos, CA | 449 | $773K |
| 4 | Brian Huh | Rheumatology | Los Angeles, CA | 458 | $771K |
| 5 | Matin Sharafatkhah | Endocrinology | Brooklyn, NY | 409 | $706K |
| 6 | Ramon Moreda | Rheumatology | Coral Gables, FL | 396 | $666K |
| 7 | David Tamura | Hematology-Oncology | Honolulu, HI | 207 | $635K |
| 8 | Gerald Ho | Rheumatology | La Palma, CA | 380 | $629K |
| 9 | Freda Hannafon | Nurse Practitioner | Rochester, NY | 408 | $626K |
| 10 | Shawn Kim | Internal Medicine | Duluth, GA | 345 | $593K |
| 11 | Yun Hee Chung | Internal Medicine | Flushing, NY | 339 | $586K |
| 12 | Guillermo Valenzuela | Rheumatology | Plantation, FL | 326 | $549K |
| 13 | Ricardo Garcia Alemany | Rheumatology | Hialeah, FL | 325 | $544K |
| 14 | Ari Baron | Hematology-Oncology | San Francisco, CA | 175 | $543K |
| 15 | Edwin Yau | Family Practice | Monterey Park, CA | 297 | $516K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 89 | Oxycodone Hcl (Oxycodone Hcl) | $213.2M | 3,537,078 |
| 90 | Brexpiprazole (Rexulti) | $204.0M | 136,378 |
| 91 | Glatiramer Acetate (Copaxone) | $203.6M | 40,986 |
| 92 | Denosumab (Prolia) | $199.4M | 114,710 |
| 93 | Ticagrelor (Brilinta) | $195.8M | 293,897 |
| 94 | Lurasidone Hcl (Latuda) | $190.9M | 254,237 |
| 95 | Darolutamide (Nubeqa) | $188.8M | 14,375 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology